J1094 HCPCS code: Injection, dexamethasone acetate, 1 mg
J1094 is the HCPCS Level II code for injection, dexamethasone acetate, 1 mg. CMS terminated J1094 on 2025-03-31; do not bill it for later dates of service. In 2023 Medicare paid an average of $1.40 per service for J1094 across 27 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. In 2023, about 10 clinicians billed Medicare for J1094 for 11 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2003-01-01 |
| Last action effective | 2025-04-01 |
| Terminated | 2025-03-31 |
Who bills J1094 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 10 |
| Medicare beneficiaries | 11 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1094, 2023–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 27 | 11 | $1.76 | $1.40 |
What changed for J1094
- 2003-01-01: J1094 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1094?
J1094 is the HCPCS Level II code for injection, dexamethasone acetate, 1 mg. Short descriptor: "Inj dexamethasone acetate".
How much does Medicare pay for J1094?
In 2023, the average Medicare payment was $1.40 per service (average allowed $1.76).
Does Medicare cover J1094?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1020 — Injection, methylprednisolone acetate, 20 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1072 — Injection, testosterone cypionate (azmiro), 1 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
- J1095 — Injection, dexamethasone 9 percent, intraocular, 1 microgram
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1094
- Watch J1094 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1094
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.